InteliCare Holdings Ltd (ASX: ICR) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

InteliCare Holdings Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $3.40 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 487.89 million
Earnings per share -0.010
Dividend per share N/A
Year To Date Return -66.67%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • InteliCare Holdings Ltd (ASX: ICR)
    Latest News

    No posts found.

    ICR ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About InteliCare Holdings Ltd

    InteliCare Holdings Ltd is an Australian firm engaged in the Production of a predictive analytics solution for care providers in the aged care, disability and healthcare sectors, Sales and marketing and Research and development activities.Its platform provides families and caregivers with a real-time view of the well-being of people in an independent living environment. The product portfolio includes InteliCare Hub, Smart sensors, Downloadable Applications, and Optional Duress Pendants. Substantial revenue comes from hardware sales.

    ICR Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    20 Dec 2024 $0.01 $0.00 0.00% 154,351 $0.01 $0.01 $0.01
    18 Dec 2024 $0.01 $0.00 0.00% 100,000 $0.01 $0.01 $0.01
    13 Dec 2024 $0.01 $0.00 0.00% 280,000 $0.01 $0.01 $0.01
    12 Dec 2024 $0.01 $0.00 0.00% 4,775,555 $0.01 $0.01 $0.01
    11 Dec 2024 $0.01 $0.00 0.00% 1,707,708 $0.01 $0.01 $0.01
    10 Dec 2024 $0.01 $0.00 0.00% 500,000 $0.01 $0.01 $0.01
    09 Dec 2024 $0.01 $0.00 0.00% 297,506 $0.01 $0.01 $0.01
    06 Dec 2024 $0.01 $0.00 0.00% 90,909 $0.01 $0.01 $0.01
    05 Dec 2024 $0.01 $0.00 0.00% 692,128 $0.01 $0.01 $0.01
    03 Dec 2024 $0.01 $0.00 0.00% 1,165,329 $0.01 $0.01 $0.01
    02 Dec 2024 $0.01 $0.00 0.00% 100,000 $0.01 $0.01 $0.01
    29 Nov 2024 $0.01 $0.00 0.00% 398,665 $0.01 $0.01 $0.01
    28 Nov 2024 $0.01 $0.00 0.00% 418,008 $0.01 $0.01 $0.01
    26 Nov 2024 $0.01 $0.00 0.00% 210,000 $0.01 $0.01 $0.01

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    30 Aug 2024 Greg Leach Issued 4,166,667 $66,666
    Placement.
    30 Aug 2024 Greg Leach Issued 12,500,000 $100,000
    Placement.
    30 Aug 2024 Greg Leach Issued 1,363,636 $30,000
    Placement.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Neale William Fong Non-Executive ChairmanNon-Executive Director Apr 2022
    Mr Fong is a registered medical practitioner with over 35 years of experience in a range of leadership roles in the private and public hospital systems. Neale is CEO and Executive Director of Bethesda Health Care, Chair of the Western Australian Country Health Service, Chairman of the Wyllie Group and President of the Australasian College of Health Service Management. Neale was previously the Director General of the WA Department of Health, CEO of St John of God Subiaco, Deputy Chair of the Bethanie Aged Care Group and Professor of Healthcare Leadership and Director of the Curtin Health Innovation Research Institute at Curtin University.
    Mr Timothy (Tim) Chapman Non-Executive Director Sep 2024
    Mr Chapman has over 25 years experience in financial services, having advised on a myriad of corporate transactions and capital raisings for public and private companies through IPOs, private placements, reverse takeovers and many mergers and acquisitions. Tim has spent the past 15 years of his career advising micro and small companies across a range of industries but with a focus on healthcare and health tech. Tim is currently the chairman of HeraMED (ASX:HMD), a medical data company leading the digital transformation of maternity care with state-ofthe-art technology and human centred experience design. Tim is also Founder and Executive Director of Clarity Capital Advisors Pty Ltd, through which he has been supporting InteliCare in an advisory capacity over the past 18 months.
    Mr Greg Leach Non-Executive Director
    Mr Leach is a founder of InteliCare and has been in the Information and Communications Technology industry for over 30 years and during that time has established and continues to oversee multiple successful companies and held multiple executive level roles spanning management, technology and innovation. He also co-founded Frontline Services (of which he is a director), BigRedSky Limited and founded Alkypro Fuel Systems. He founded and is currently a director and CEO of Blockhead Technologies Pty Ltd.
    Mr Neil John Hackett Company Secretary Oct 2020
    -
    Mr Daniel Pilbrow Chief Executive Officer Apr 2022
    -
    Daniel Pilbrow Chief Executive Officer
    -
    Mike Tappenden Chief Technology Officer
    -
    Neil John Hackett Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Mtgl Pty Ltd 36,372,848 7.46%
    Melbourne Securities Corporation Ltd <Bv1 Fund A/C> 33,060,387 6.78%
    Citicorp Nominees Pty Limited 30,936,145 6.35%
    Ratdog Pty Ltd 20,053,839 4.12%
    Kyriaco Barber Pty Ltd 17,250,000 3.54%
    Powerhouse Ventures Limited 15,625,000 3.21%
    JAF Capital Pty Ltd 15,000,000 3.08%
    Tanakorn Pty Ltd 13,863,636 2.84%
    Charlton Wa Pty Ltd <Tinamara Super Fund A/C> 13,500,000 2.77%
    Ilwella Pty Ltd <No 2 A/C> 13,300,000 2.73%
    Schammer Pty Ltd <Bs Super Fund A/C> 12,229,545 2.51%
    Kyriaco Barber Pty Ltd i 11,026,189 2.26%
    Ml Carr Pty Ltd <Carr Family A/C> 9,375,000 1.92%
    Pyap Park Pty Ltd <Pd & Bg Schammer S/Fund A/C> 9,320,183 1.91%
    Scintilla Strategic Investments Limited 9,186,364 1.89%
    Isidore 14 Pty Ltd <Gibson Family A/C> 9,000,000 1.85%
    Chris Eastwell Pty Ltd <Cme Super Fund A/C> 7,154,354 1.47%
    Loxton Resources Pty Ltd 6,865,918 1.41%
    Mr Christopher James Weed & Mrs Janet Elizabeth Brockman <Brockman Weed Family 2 A/C> 6,613,636 1.36%
    Sugar Enterprises Pty Ltd <Kane Johnson Super Fund A/C> 6,127,668 1.25%

    Profile

    since

    Note